Noble metal nanoparticles have received much attention due to their interesting properties that make them useful in different technical fields. Metallic nanoparticles with optical properties in the near infrared region of the electromagnetic spectrum are of great importance for biological applications, in particular photothermal therapy, as it is greatly enhanced by metallic nanoparticles. However, despite the large amount of work that has been done with metallic nanoparticles for thermal therapy, there is a reduced amount of scientific reports about the photothermal stability of most studied nanoparticles. In this work, hollow Au–Ag bimetallic nanoparticles were synthesized via galvanic replacement reaction, with optical properties that can be tuned systematically along the visible and near infrared region of the spectrum, by changing the pH before the synthesis of the templates and by controlling the amount of gold added for the synthesis of the nanoshells. The synthesized nanoparticles exhibit good photothermal properties when illuminated with an 808 nm laser light. An increase of temperature of nearly 20 °C is achieved after 15 minutes of irradiation. Moreover, the Au–Ag nanoparticles show good reusability even after ten heating/cooling cycles. The nanoparticles also retain their optical properties after 12 hours of continuous irradiation and are able to maintain their photothermal characteristics of increasing the temperature at the same levels during the entire process.

A new prospect for the synthesis of molecularly imprinted polymers: photo-iniferter polymerization under visible light.

Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic) are the nanoclays that have advanced into the vaccinology field. Until now, only physisorption has been used to modify the surface of nanoclays with antigens, adjuvants, and/or ligands to create nanovaccines. Protocols to covalently attach these molecules have not been developed with nanoclays, only procedures to develop adsorbents based on nanoclays that could be extended to develop nanovaccine conjugates. In this review, we describe the approaches evaluated on different nanovaccine candidates reported in articles, the immunological results obtained with them and the most advanced approaches in the preclinical field, while describing the nanomaterial itself. In addition, complex systems that use nanoclays were included and described. The safety of nanoclays as carriers is an important key fact to determine their true potential as nanovaccine candidates in humans. Here, we present the evaluations reported in this field. Finally, we point out the perspectives in the development of vaccine prototypes using nanoclays as antigen carriers.

Introduction: The development of innovative anti-COVID-19 vaccines is a need to ensure the population’s immunity worldwide, with broad protection against variants of concern and low cost as the main goals. Gold nanocarriers are potential entities that could aid in the development of innovative vaccines having thermal stability, high immunogenicity, and safety as the main attributes. Moreover, this approach could lead to adjuvant-free formulations, which will reduce the costs of vaccines.Methods: In this study, five peptides (P₁, P₂, P₃, P₄, and P₅) corresponding to linear epitopes of the SARS-CoV-2 spike (S) protein were chemisorbed on gold nanoparticles (AuNP) of 20 nm, prefunctionalized with heterobifunctional polyethylene glycol, by using glutaraldehyde as crosslinker to generate nanovaccine prototypes.Results and discussion: The surface modification was confirmed by DLS with an increase of 31.7 ± 1.8 nm in the hydrodynamic diameter and an average ζ potential of −8.3 ± 2.2 mV in PBS (as excipient). The coupling concentration achieved was 23.7 ± 7.1 μg of peptide per mg AuNP. These AuNP-based conjugates showed no inherent toxicity in assays performed with HEK293T cells, in which a 100–1,000 μg/mL concentration range only led to a temporary decrease of up to 30% in cell viability after 48 h of treatment with restoration by 72 h. The immunogenicity of the conjugates produced was assessed in test mice subjected to three subcutaneous doses at 2-week intervals. Significant levels of IgM against each target peptide were observed at an early stage of the immunization scheme in all groups, reaching maximum levels after the second dose, whereas the IgG response increased after the third dose. The AuNP-P₂, AuNP-P₃, and AuNP-P₅ conjugates induced the highest levels of IgG antibodies, lasting for at least 2 months after the last boost, with a predominance of the IgG1 subclass. Although the magnitude of the response induced by the gold conjugates was comparable to that with alum as adjuvant, these nanoconjugates induced a longer response. Our data support the use of AuNP as carriers in innovative vaccines against SARS-CoV-2.